(Photo by Flickr user pablo:espinosa, used under a Creative Commons license)
Pharma giant AstraZeneca has put its U.S. HQ up for sale. Fear not, though, according to a News Journal report: the drugmaker is looking to sell the Fairfax campus and then lease space from the new owner.
“In order to fully explore this [redevelopment] possibility, AstraZeneca will be soliciting bids from real estate developers in the coming months and that requires us putting the site on the market for sale,” AstraZeneca spokeswoman Abigail Bozrath told the paper.
The company expressed interest in relocating or redesigning its U.S. home base in a statement back in May.
What’s your Zoom view?
Wilmington office market: Survey says 40% of tenants don’t yet have a reoccupancy plan
Coworking space CSC Station is on track for an October opening
CSC’s downtown location will be more than another office
Sign-up for daily news updates from Technical.ly Delaware